Claudia De Lorenzo

17PUBLICATIONS
36CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsMedical molecular engineering of nucleic acids and proteinsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 27, 2025
A Novel Human Anti-FV mAb as a Potential Tool for Diagnostic and Coagulation Inhibitory Approaches.

Margherita Passariello, Rosa Rapuano Lembo, Lorenzo Manna

|Feb 10, 2025
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics.

Margherita Passariello, Lorenzo Manna, Rosa Rapuano Lembo

|Nov 25, 2023
A Comparison of the Antitumor Efficacy of Novel Multi-Specific Tribodies with Combinations of Approved Immunomodulatory Antibodies.

Lorenzo Manna, Rosa Rapuano Lembo, Asami Yoshioka

|Jun 28, 2023
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays.

Margherita Passariello, Speranza Esposito, Lorenzo Manna

|Nov 11, 2022
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC.

Rosa Rapuano Lembo, Lorenzo Manna, Guendalina Froechlich

|May 28, 2022
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab.

Margherita Passariello, Veronica Ferrucci, Emanuele Sasso

Pageof 3

Frequent Collaborators

6 joint publications

Emanuele Sasso

6 joint publications

Nicola Zambrano

2 joint publications

Felice Amato

2 joint publications

Massimo Zollo